Von Willebrand factor/coagulation factor VIII complex (human, Octapharma)

N/A

Report date: 2024/11/21 10:27:52

Base Information

Drug NameVon Willebrand factor/coagulation factor VIII complex (human, Octapharma)
Drug Alias Name凝血因子VIII (human, Octapharma)Factor VIII/von Willebrand factor (Octapharma)血管性血友病 (human, Octapharma)WilnativWilate +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsVon willebrand factor replacements +[4] 
TargetsCoagulation factor VIIICoagulation factor X
Therapy Area/Indicationsvon Willebrand DiseasesHemophilia A
Global Approved Indicationsvon Willebrand DiseasesHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2005/01/01
Country/TerritoryBulgariaUnited StatesUkraine +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOctapharma
China Registration ClassN/A

Develop Information

Active CompaniesOctapharma
Inactive CompaniesN/A
Active Indicationsvon Willebrand DiseasesHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD06
Related LinksN/A